Currently, Tocilizumab is Expensive and in Short Supply Globally. WHO and Partners Are ... - Latest Tweet by World Health Organization

Currently, tocilizumab is expensive and in short supply globally. WHO and partners are currently discussing lower prices and improved access in low- and middle-income countries with the producer.
 
More info 👉https://t.co/yKLEAXCUtu— World Health Organization (WHO) (@WHO) February 11, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)